IL134045A0 - Treatment of diabetes with thiazolidinedione and sulphonylurea - Google Patents

Treatment of diabetes with thiazolidinedione and sulphonylurea

Info

Publication number
IL134045A0
IL134045A0 IL13404598A IL13404598A IL134045A0 IL 134045 A0 IL134045 A0 IL 134045A0 IL 13404598 A IL13404598 A IL 13404598A IL 13404598 A IL13404598 A IL 13404598A IL 134045 A0 IL134045 A0 IL 134045A0
Authority
IL
Israel
Prior art keywords
sulphonylurea
thiazolidinedione
diabetes
treatment
Prior art date
Application number
IL13404598A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134045(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL134045A0 publication Critical patent/IL134045A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13404598A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea IL134045A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002109 WO1999003476A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (1)

Publication Number Publication Date
IL134045A0 true IL134045A0 (en) 2001-04-30

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13404598A IL134045A0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione and sulphonylurea

Country Status (40)

Country Link
EP (1) EP0998291B2 (en, 2012)
JP (2) JP2001510158A (en, 2012)
KR (1) KR100680667B1 (en, 2012)
CN (1) CN1264302A (en, 2012)
AP (1) AP1318A (en, 2012)
AR (2) AR016768A1 (en, 2012)
AT (1) ATE366577T1 (en, 2012)
AU (1) AU743269B2 (en, 2012)
BG (1) BG64892B1 (en, 2012)
BR (1) BR9810904A (en, 2012)
CA (1) CA2297115C (en, 2012)
CO (1) CO4940422A1 (en, 2012)
CY (1) CY1107745T1 (en, 2012)
CZ (1) CZ302668B6 (en, 2012)
DE (1) DE69838066T3 (en, 2012)
DK (1) DK0998291T4 (en, 2012)
DZ (1) DZ2564A1 (en, 2012)
EA (1) EA003303B1 (en, 2012)
ES (1) ES2290989T5 (en, 2012)
GB (1) GB9715306D0 (en, 2012)
HU (1) HU229119B1 (en, 2012)
ID (1) ID24198A (en, 2012)
IL (1) IL134045A0 (en, 2012)
IN (1) IN189035B (en, 2012)
MA (1) MA26522A1 (en, 2012)
MY (1) MY138246A (en, 2012)
NO (1) NO326356B1 (en, 2012)
NZ (3) NZ520652A (en, 2012)
OA (1) OA11632A (en, 2012)
PE (1) PE99799A1 (en, 2012)
PL (2) PL199125B1 (en, 2012)
PT (1) PT998291E (en, 2012)
SI (1) SI0998291T2 (en, 2012)
SK (2) SK287823B6 (en, 2012)
TR (1) TR200000135T2 (en, 2012)
TW (1) TW586926B (en, 2012)
UA (1) UA70302C2 (en, 2012)
UY (1) UY25103A1 (en, 2012)
WO (1) WO1999003476A1 (en, 2012)
ZA (1) ZA986365B (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
EP1738751B1 (en) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd Spaced drug delivery system
NZ546337A (en) * 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
AR058605A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Preparacion solida

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group P.L.C., Brentford Substituierte Thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
FI904414A0 (fi) * 1988-03-08 1990-09-07 Pfizer Tiazolidindion-hypoglykemiskt verkande aemnen.
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
PT998291E (pt) 2007-10-11
DE69838066D1 (de) 2007-08-23
KR20010021948A (ko) 2001-03-15
KR100680667B1 (ko) 2007-02-09
HU229119B1 (en) 2013-08-28
NZ515555A (en) 2002-09-27
UY25103A1 (es) 2000-12-29
MY138246A (en) 2009-05-29
SK287823B6 (sk) 2011-11-04
SK288053B6 (sk) 2013-03-01
HUP0003634A2 (hu) 2001-07-30
HK1029272A1 (en) 2001-03-30
NO326356B1 (no) 2008-11-17
NZ520652A (en) 2004-06-25
EP0998291B2 (en) 2011-07-06
PE99799A1 (es) 1999-12-22
AR016768A1 (es) 2001-08-01
CZ2000173A3 (en) 2001-05-16
ATE366577T1 (de) 2007-08-15
BR9810904A (pt) 2000-09-26
NO20000229D0 (no) 2000-01-17
CO4940422A1 (es) 2000-07-24
SI0998291T1 (sl) 2007-12-31
SI0998291T2 (sl) 2011-10-28
SK602000A3 (en) 2000-07-11
ZA986365B (en) 2000-01-17
DE69838066T3 (de) 2012-03-29
DZ2564A1 (fr) 2003-02-15
CA2297115A1 (en) 1999-01-28
ES2290989T5 (es) 2011-11-11
HUP0003634A3 (en) 2003-04-28
NZ501256A (en) 2002-09-27
JP2005247865A (ja) 2005-09-15
CA2297115C (en) 2010-02-23
EA200000141A1 (ru) 2000-08-28
EP0998291B1 (en) 2007-07-11
AU8448798A (en) 1999-02-10
GB9715306D0 (en) 1997-09-24
ID24198A (id) 2000-07-13
PL199125B1 (pl) 2008-08-29
CN1264302A (zh) 2000-08-23
PL338127A1 (en) 2000-09-25
AP2000001734A0 (en) 2000-03-31
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
EP0998291A1 (en) 2000-05-10
CY1107745T1 (el) 2013-04-18
DK0998291T4 (da) 2011-09-26
BG104139A (en) 2000-11-30
TR200000135T2 (tr) 2000-05-22
AP1318A (en) 2004-10-22
JP2001510158A (ja) 2001-07-31
AU743269B2 (en) 2002-01-24
AR019331A2 (es) 2002-02-13
TW586926B (en) 2004-05-11
UA70302C2 (uk) 2004-10-15
DK0998291T3 (da) 2007-11-05
NO20000229L (no) 2000-01-17
WO1999003476A1 (en) 1999-01-28
IN189035B (en, 2012) 2002-12-07
ES2290989T3 (es) 2008-02-16
MA26522A1 (fr) 2004-12-20
OA11632A (en) 2004-11-22
CZ302668B6 (cs) 2011-08-24
BG64892B1 (bg) 2006-08-31

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
IL127219A0 (en) The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same
AU5840200A (en) Treatment of diabetes and related pathologies
AP2000001733A0 (en) Treatment of diabetes with thiazolidinedione insulin secretagogue and diguanide
IL133143A0 (en) Treatment of diabetes with rosiglitazone and insulin
IL133137A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
PL337577A1 (en) Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor
AU4107797A (en) Compounds for the treatment and prevention of diabetes
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
ZA989514B (en) Treatment of diabetic retinopathy
HK1025263A (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
IL121656A0 (en) Diagnosis prevention and treatment of diabetes
GB9618290D0 (en) Treatment of diabetes
GB9812314D0 (en) Treatment of diabetes
GB9815149D0 (en) Treatment of diabetes
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
GB9609897D0 (en) Treatment of diabetes